Latest Breaking News On - Multidrug resistant tumours - Page 1 : comparemela.com

On 29 June 2022, COST’s governing board, the Committee of Senior Officials (CSO) approved funding for six new COST Innovators Grants (CIGs). What is a COST Innovators Grant?

European network for the disseminationCommittee of senior officialsSenior officialsGrapevine genomics encyclopediaEuropean educational platformMultidrug resistant tumoursPersonalised cancer treatmentPreclinical assessmentCardioprotective therapies